All protocols
Semaglutide / Tirzepatide
GLP-1 Metabolic Research
Weekly-dosed protocols for GLP-1 and GIP receptor studies. Reconstitution math and dose escalation follow SURMOUNT / SURPASS / STEP trial designs.
Research goal
GLP-1 axis and metabolic investigations
Duration
12–52 weeks depending on study endpoints
Weekly schedule
Week 1–40.25 mg once weekly (starting dose)
Week 5–80.5 mg once weekly
Week 9–121.0 mg once weekly
Week 13+Escalate per protocol (max 2.4 mg semaglutide / 15 mg tirzepatide)
Reconstitution notes
- •Reconstitute 5mg vial with 2 mL bacteriostatic water → 0.1 mL = 0.25 mg
- •Start low, escalate every 4 weeks
- •Rotate injection sites in the research protocol
Peptides in this protocol
Need the peptides for this protocol?
Inquire via WhatsAppFor Research Use Only. This protocol summarizes doses reported in peer-reviewed studies. It is not medical advice.